focus -WSS

focus

author：knowledge 2025-10-02 22:23:52 - browse：26

Katie Palmer, STAT (left) moderating the Doctor vs. ChatGPT session during the 2023 STAT Summit. STAT

Generative AI tools are already helping doctors transcribe visits and summarize patient records. The technology behind ChatGPT, trained on vast amounts of data from the internet, made headlines when it correctly answered more than 80% of board exam questions. In July, a team at Beth Israel saw promising results when using GPT-4 during a diagnosis workshop for medical residents.

But the tool is by no means ready for primetime. When given questions about real-life medical scenarios by Stanford researchers, GPT frequently disagreed with humans or offered irrelevant information. The AI models are prone to “hallucinating,” or making things up because they sound right — a tendency that could cause immeasurable harm if let loose on patients. AI leaders and policymakers alike have called for more regulations.

STAT decided to put ChatGPT to the test at its annual summit on Wednesday, pitting the tool against Ann Woolley, infectious disease specialist at Brigham and Women’s Hospital. Marc Succi, the associate innovation chair at Mass General Brigham, gave two patient scenarios to the tool while Woolley explained her own diagnoses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Weight loss drugs aren’t covered by Obamacare. That may change

hotspot

WSS

The Readout: Lenmeldy, GLP

Eliminate the waiting period for sterilization covered by Medicaid

Hospitals are piloting generative AI tools as regulators play catch

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Why the world’s most expensive drug might be worth the price

Scientists boost immune system in aging mice by making it youthful

focus

focus

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

Supreme Court mifepristone arguments center on docs' right to sue

Anesthesiologist group: stop taking Ozempic before surgery

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Psychedelics group wrestles with new pharma identity

Measles policy set amid Florida outbreak alarms vaccine proponents

Drug repurposing or repositioning? The language matters

As AI regulations shape up, health tech startups beg for clarity

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Congress may force more Covid

hotspot

Donor acceptance rates hint at racial, gender bias in heart transplants: study

WATCH: Why do our ears pop?

Researchers tackle phage therapy hurdles for wider adoption

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Why the world’s most expensive drug might be worth the price

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

hotspot

hotspot

hotspot

hotspot